Chemotherapy-Induced Survivin Regulation in Acute Myeloid Leukemia Cells
Survivin is a 16.5 kDa protein highly expressed in centrosomes, where it controls proper sister chromatid separation. In addition to its function in mitosis, survivin is also involved in apoptosis. Overexpression of survivin in many cancer types makes it a suitable target for cancer therapy. Western...
Main Authors: | Petra Otevřelová, Barbora Brodská |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/11/1/460 |
Similar Items
-
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
by: Young Hoon Park, et al.
Published: (2022-07-01) -
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
by: Prajwal Boddu, et al.
Published: (2018-09-01) -
Idarubicin versus Doxorubicin in Acute Myeloid Leukemia: A Parallel Randomized Trial with Pharmacoeconomic Analysis
by: Amany El Zeiny, et al.
Published: (2024-01-01) -
MS‐275 potentiates the effect of YM‐155 in lung adenocarcinoma via survivin downregulation induced by miR‐138 and miR‐195
by: Bai‐Ling Luo, et al.
Published: (2019-06-01) -
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
by: Martin Michaelis, et al.
Published: (2020-03-01)